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Background Cardiac surgery using cardiopulmonary bypass is a complex procedure, sometimes 
accompanied with excessive bleeding. The nature and pathophysiology of this bleeding is 
multifactorial and not completely understood. Fibrinogen is a final step in the coagulation cascade 
and its substitution can alter postoperative hemorrhage. 
 Aim To investigate different aspects of plasma coagulation in cardiac surgery. Firstly, to assess 
potential changes in coagulation factor levels during surgery and its relation to bleeding. Secondly, to 
study plasma’s potential to generate thrombin after cardiac surgery. Thirdly, to compare two 
different protocols to dose the anticoagulant heparin in regard to thrombin generation capacity. 
Fourthly, to investigate effects of recombinant human fibrinogen ex vivo.  
Material and methods In study I, coagulation factor activities were measured before and after 
surgery in a cohort of 57 patients undergoing first time elective coronary artery bypass grafting 
(CABG). Study II comprises the same cohort, now measuring thrombin generation potential using 
calibrated automated thrombography (CAT). Study III is a prospective trial, randomizing 60 elective 
CABG or valve replacement patients to either anticoagulation with weight-based heparin dosing or 
using heparin and protamine titration with a bedside device. In study IV, plasma of 10 cardiac surgery 
patients was spiked with various concentrations of human plasma derived fibrinogen or recombinant 
human fibrinogen. Ex vivo clot formation was assessed by rotational thromboelastometry.  
Results There was pronounced variation in level of individual coagulation factors after surgery. 
Concentration of fibrinogen and FXIII showed a weak correlation to bleeding volume 12 hours after 
surgery. Pronounced deterioration of thrombin generation capacity was found, possibly caused by 
persistent heparin effect and/or heparin rebound. Different heparin dosing protocols had no effect 
on per- and postoperative plasma’s thrombin generation capacity or on bleeding volume. Ex vivo, 
there was no difference between the new recombinant human fibrinogen concentrate and the one 
plasma derived regarding clot formation ability.  
Conclusions Postoperative decline (or rise) of individual coagulation factors does not seem to affect 
the postoperative bleeding volume, with reservation for fibrinogen and FXIII. Heparin effect is still 
present at 2 and 4 hours after surgery, affecting thrombin generation. More precise heparin and 
protamin dosing protocol does not influence this phenomenon. Recently manufactured recombinant 
human fibrinogen concentrate is able to generate a clot of similar viscoelastic properties as plasma 
derived. 
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